obesity drug news today october 21 2025 glp-1 Pharma Giants Bet on Next-Generation Treatments to Sustain Growth GLP-1 gains meet modest obesity
Description
Our findings underscore the possibility for wider applications for these medications but also highlight important risks that should be carefully monitored in people taking these drugs.
Out-of-Pocket Costs Without Coverage If you don't qualify for the GLP-1 Bridge or prefer not to wait until July 2026, here's what you can expect to pay out of pocket in 2026: Approximate Monthly Costs (Without Insurance) Ozempic: ~$199-$499/month through manufacturer savings programs (list price ~$998) Wegovy: ~$149-$199/month through savings programs (list price ~$1,350) Zepbound: ~$349/month through LillyDirect (list price ~$1,060) Mounjaro: ~$349/month through LillyDirect (list price ~$1,060) Freedom and Legacy Advisors St
The Microdose GLP-1 Protocol starts at $129 monthly and delivers lower-concentration GLP-1 therapy, ideal for patients new to peptide medication or sensitive to standard dosing protocols
Reddy's Laboratories Find Brensocatib bulk offered by Dr
Is the Precision Peptide Genetic Test covered by HSA or FSA funds
